z-logo
open-access-imgOpen Access
ANALYSIS OF TUBERCULOSIS TREATMENT SUITABILITY AND THE DRUG SUPERVISOR’S ROLE IN A COMMUNITY HEALTH CENTER IN PADEMANGAN SUBDISTRICT, NORTH JAKARTA
Author(s) -
Febriony Citra,
Purwantyastuti,
MEANALDI RASMIN,
Vivian Soetikno
Publication year - 2019
Publication title -
international journal of applied pharmaceutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.238
H-Index - 15
ISSN - 0975-7058
DOI - 10.22159/ijap.2019.v11s1.030
Subject(s) - medicine , tuberculosis , sputum , drug , intervention (counseling) , community health center , directly observed therapy , family medicine , pharmacology , nursing , pathology
Objective: Appropriate tuberculosis (TB) treatment guidelines are one of the many factors that influence the success of TB treatment. The patient’sdrug supervisor is a functional role that is part of the directly observed treatment short course, a program to support the success of TB treatment.The aim of this study was to analyze the TB treatment suitability in a community health center and the benefit of treatment compliance supervisionby the patient’s designated drug supervisor.Methods: We conducted a cross-sectional study in the Community Health Center of Pademangan subdistrict, North Jakarta, involving 205 subjects toanalyze appropriate fixed-dose combination (FDC) anti-TB drug administration and an experimental study involving 23 control group TB patients and23 intervention group TB patients to assess the benefit of supervision by each patient’s drug supervisor.Results: The association of FDC anti-TB drug side effects with the success of TB treatment was not statistically significant (p=0.173). There wasan increase in drug supervisor knowledge of 8.6% in the intervention group and 13% in the control group. There was no statistically significantassociation between the knowledge of the drug supervisor and the 2nd month (p=0.575) and the 6th month of sputum treatment.Conclusion: Minor side effects of FDC anti-TB drug did not affect the success of TB treatment; therefore, treatment was continued if these adverseevents occurred. There were no correlations between the drug supervisor knowledge level with medication compliance or with sputum conversion(months 2 and 6).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom